Dramatic erythroid response to low‐dose thalidomide in two patients with transfusion independent thalassemia and severe post‐transfusional alloimmune hemolysis

versus conventional care regimens in olders patients with newly diagnosed acute myeloid leukemia. EHA Annual Meeting Abstracts 2014:LB-6212. 11. Kantarjian HM, Thomas XG, Dmoszynska A, et al. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol 2012;30:2670–2677. 12. Cashen AF, Schiller GJ, O’Donnell MR, et al. Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. J Clin Oncol 2010;28:556– 561. 13. Lubbert M, Ruter BH, Claus R, et al. A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy. Haematologica 2012;97:393–401. 14. Ritchie EK, Feldman EJ, Christos PJ, et al. Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia. Leuk Lymphoma 2013;54:2003–2007.

[1]  S. Philipsen,et al.  Transfusion-independent β(0)-thalassemia after bone marrow transplantation failure: proposed involvement of high parental HbF and an epigenetic mechanism. , 2014, American journal of blood research.

[2]  M. Soleimani,et al.  The Role of Epigenetics in the Induction of Fetal Hemoglobin: A Combination Therapy Approach , 2014, International journal of hematology-oncology and stem cell research.

[3]  J. Scandura,et al.  Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia , 2013, Leukemia & lymphoma.

[4]  M. Shahjahani,et al.  Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders , 2013, International journal of hematology-oncology and stem cell research.

[5]  Rongrong Liu,et al.  Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China , 2010, Journal of hematology & oncology.

[6]  J. Dipersio,et al.  Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  G. Masera,et al.  Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy. , 2010, Blood transfusion = Trasfusione del sangue.

[8]  J. L. Delgado-Lamas,et al.  Thalidomide therapy in a patient with thalassemia major. , 2008, Blood cells, molecules & diseases.

[9]  D. Verhelle,et al.  Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells. , 2008, Journal of Clinical Investigation.